×
Nihon Kohden Price to Free Cash Flow Ratio 2015-2024 | NHNKY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Nihon Kohden price to free cash flow ratio from 2015 to 2024. Price to free cash flow ratio can be defined as
View More
Nihon Kohden Price to Free Cash Flow Ratio 2015-2024 | NHNKY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Nihon Kohden price to free cash flow ratio from 2015 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
Intuitive Surgical (ISRG)
$216.7B
Thermo Fisher Scientific (TMO)
$203.1B
Alcon (ALC)
$44.2B
Edwards Lifesciences (EW)
$44B
IDEXX Laboratories (IDXX)
$36.9B
DexCom (DXCM)
$35B
IQVIA Holdings (IQV)
$34.6B
Mettler-Toledo (MTD)
$27.3B
Waters (WAT)
$22.4B
STERIS (STE)
$21.8B
SONOVA HOLDING (SONVY)
$19.6B
Hologic (HOLX)
$14.4B
Fresenius Medical Care AG KGaA (FMS)
$13.6B
Penumbra (PEN)
$11.7B
Sysmex ADR (SSMXY)
$11.5B
Globus Medical (GMED)
$11.5B
Masimo (MASI)
$9.6B
Glaukos (GKOS)
$8.9B
Teleflex (TFX)
$8.1B
Integer Holdings (ITGR)
$4.8B
Inari Medical (NARI)
$4.7B
PROCEPT BioRobotics (PRCT)
$3.5B
Veracyte (VCYT)
$3.3B
TransMedics (TMDX)
$2.7B
LivaNova (LIVN)
$2.6B
Elekta AB (EKTAY)
$2.3B
Tandem Diabetes Care (TNDM)
$2.1B
Integra LifeSciences Holdings (IART)
$1.7B
Alphatec Holdings (ATEC)
$1.5B
Pulse Biosciences (PLSE)
$1.2B